» Articles » PMID: 28771236

The Cubicon Method for Concentrating Membrane Proteins in the Cubic Mesophase

Overview
Journal Nat Protoc
Specialties Biology
Pathology
Science
Date 2017 Aug 4
PMID 28771236
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The lipid cubic phase (in meso) method is an important approach for generating crystals and high-resolution X-ray structures of integral membrane proteins. However, as a consequence of instability, it can be impossible-using traditional methods-to concentrate certain membrane proteins and complexes to values suitable for in meso crystallization and structure determination. The cubicon method described here exploits the amphiphilic nature of membrane proteins and their natural tendency to partition preferentially into lipid bilayers from aqueous solution. Using several rounds of reconstitution, the protein concentration in the bilayer of the cubic mesophase can be ramped up stepwise from less than a milligram per milliliter to tens of milligrams per milliliter for crystallogenesis. The general applicability of the method is demonstrated with five integral membrane proteins: the β-adrenergic G protein-coupled receptor (βAR), the peptide transporter (PepT), diacylglycerol kinase (DgkA), the alginate transporter (AlgE) and the cystic fibrosis transmembrane conductance regulator (CFTR). In the cases of βAR, PepT, DgkA and AlgE, an effective 20- to 45-fold concentration was realized, resulting in a protein-laden mesophase that allowed the formation of crystals using the in meso method and structure determination to resolutions ranging from 2.4 Å to 3.2 Å. In addition to opening up in meso crystallization to a broader range of integral membrane protein targets, the cubicon method should find application in situations that require membrane protein reconstitution in a lipid bilayer at high concentrations. These applications include functional and biophysical characterization studies for ligand screening, drug delivery, antibody production and protein complex formation. A typical cubicon experiment can be completed in 3-5 h.

Citing Articles

G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.

Szwabowski G, Griffing M, Mugabe E, OMalley D, Baker L, Baker D Int J Mol Sci. 2024; 25(13).

PMID: 38999982 PMC: 11241240. DOI: 10.3390/ijms25136876.


Lipid-based liquid crystalline materials in electrochemical sensing and nanocarrier technology.

Zatloukalova M, Poltorak L, Bilewicz R, Vacek J Mikrochim Acta. 2023; 190(5):187.

PMID: 37071228 PMC: 10113356. DOI: 10.1007/s00604-023-05727-w.


Quinone binding sites of cyt bc complexes analysed by X-ray crystallography and cryogenic electron microscopy.

Kao W, Hunte C Biochem Soc Trans. 2022; 50(2):877-893.

PMID: 35356963 PMC: 9162462. DOI: 10.1042/BST20190963.


Methods of Measuring Mitochondrial Potassium Channels: A Critical Assessment.

Walewska A, Krajewska M, Stefanowska A, Buta A, Bilewicz R, Krysinski P Int J Mol Sci. 2022; 23(3).

PMID: 35163132 PMC: 8835872. DOI: 10.3390/ijms23031210.


Structural snapshots of human PepT1 and PepT2 reveal mechanistic insights into substrate and drug transport across epithelial membranes.

Killer M, Wald J, Pieprzyk J, Marlovits T, Low C Sci Adv. 2021; 7(45):eabk3259.

PMID: 34730990 PMC: 8565842. DOI: 10.1126/sciadv.abk3259.


References
1.
Misquitta Y, Cherezov V, Havas F, Patterson S, Mohan J, Wells A . Rational design of lipid for membrane protein crystallization. J Struct Biol. 2004; 148(2):169-75. DOI: 10.1016/j.jsb.2004.06.008. View

2.
Li D, Pye V, Caffrey M . Experimental phasing for structure determination using membrane-protein crystals grown by the lipid cubic phase method. Acta Crystallogr D Biol Crystallogr. 2015; 71(Pt 1):104-22. PMC: 4304691. DOI: 10.1107/S1399004714010360. View

3.
Li D, Caffrey M . Renaturing membrane proteins in the lipid cubic phase, a nanoporous membrane mimetic. Sci Rep. 2014; 4:5806. PMC: 4108929. DOI: 10.1038/srep05806. View

4.
Rasmussen S, DeVree B, Zou Y, Kruse A, Chung K, Kobilka T . Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature. 2011; 477(7366):549-55. PMC: 3184188. DOI: 10.1038/nature10361. View

5.
Cooke R, Brown A, Marshall F, Mason J . Structures of G protein-coupled receptors reveal new opportunities for drug discovery. Drug Discov Today. 2015; 20(11):1355-64. DOI: 10.1016/j.drudis.2015.08.003. View